During the COVID-19 public health emergency period, excess mortality occurred in all racial and ethnic groups, but disparities were observed.

Breakthrough measles cases vs measles cases in unvaccinated people were associated with milder disease and fewer complications.

Public concerns about contracting RSV (respiratory syncytial virus) have significantly declined during the past year.

The FDA granted Priority Review to gepotidacin for the treatment of female adults and adolescents with uncomplicated UTI.

The risk for an incident diagnosis of type 2 diabetes is increased in the 6 months following SARS-CoV-2 infection.

Member countries of the UN endorsed a broad set of commitments to address the global burden of AMR at the UNGA 2024 high-level meeting.

The Veros COVID-19 test yields accurate and rapid results and is easy to use in patients with high and moderate viral loads in the ED setting.

The Food and Drug Administration (FDA) has granted Fast Track designation to Shigella4V for the prevention of shigellosis.

Accelerated 3-year M.D. (3YMD) graduates have similar performance in medical school and early residency as 4-year M.D. (4YMD) graduates.